Literature DB >> 31812371

Cancer Immunoimaging with Smart Nanoparticles.

Yu-Chuan Ou1, Xiaona Wen1, Rizia Bardhan2.   

Abstract

Dynamic immunoimaging in vivo is crucial in patient-tailored immunotherapies to identify patients who will benefit from immunotherapies, monitor therapeutic efficacy post treatment, and determine alternative strategies for nonresponders. Nanoparticles have played a major role in the immunotherapy landscape. In this review, we summarize recent findings in immunoimaging where smart nanoparticles target, detect, stimulate, and deliver therapeutic dose in vivo. Nanoparticles interfaced with an immunoimaging toolbox enable the use of multiple modalities and achieve depth-resolved whole-body tracking of immunomarkers with high accuracy both before and after treatment. We highlight how functional nanoparticles track T cells, dendritic cells (DCs), tumor-associated macrophages (TAMs), and immune checkpoint receptors (ICRs), and facilitate image-guided interventions.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  SPIO; T cell tracking; dendritic cell tracking; gold nanoparticles; image-guided immunotherapy; immunoimaging; organic nanoparticles

Mesh:

Substances:

Year:  2019        PMID: 31812371     DOI: 10.1016/j.tibtech.2019.11.001

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  4 in total

1.  Multimodal Multiplexed Immunoimaging with Nanostars to Detect Multiple Immunomarkers and Monitor Response to Immunotherapies.

Authors:  Yu-Chuan Ou; Xiaona Wen; Christopher A Johnson; Daniel Shae; Oscar D Ayala; Joseph A Webb; Eugene C Lin; Rossane C DeLapp; Kelli L Boyd; Ann Richmond; Anita Mahadevan-Jansen; Marjan Rafat; John T Wilson; Justin M Balko; Mohammed N Tantawy; Anna E Vilgelm; Rizia Bardhan
Journal:  ACS Nano       Date:  2020-01-02       Impact factor: 15.881

Review 2.  Application of Noninvasive Imaging to Combined Immune Checkpoint Inhibitors for Breast Cancer: Facts and Future.

Authors:  Zhongquan Cheng; Yang Du; Leyi Yu; Zhu Yuan; Jie Tian
Journal:  Mol Imaging Biol       Date:  2022-01-31       Impact factor: 3.488

Review 3.  Tumor immunotherapy and multi-mode therapies mediated by medical imaging of nanoprobes.

Authors:  Yang Xuan; Meng Guan; Shubiao Zhang
Journal:  Theranostics       Date:  2021-05-25       Impact factor: 11.556

Review 4.  Surface-Enhanced Raman Spectroscopy for Cancer Immunotherapy Applications: Opportunities, Challenges, and Current Progress in Nanomaterial Strategies.

Authors:  Shuvashis Dey; Matt Trau; Kevin M Koo
Journal:  Nanomaterials (Basel)       Date:  2020-06-11       Impact factor: 5.076

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.